Fenofibrate
- Product NDC
- 68071-3542
- Requested package NDC
- 68071-3542-9
- 11-digit product format
- 680713542
- Labeler code
- 68071
- Product ID
- 68071-3542_2d3fb146-e3be-92bf-e063-6394a90a1b3a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fenofibrate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA216798
- Marketing category
- ANDA
- Marketing start
- 2022-09-27
- Substance
- FENOFIBRATE
- Active strength
- 160 mg/1
- Pharmacologic classes
- Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68071-3542 | 68071-3542-9 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68071-3542 | 68071-3542-9 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68071-3542 | 68071-3542-9 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216798-001 | FENOFIBRATE | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | |
| A216798-002 | FENOFIBRATE | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216798-001 | AB |
| A216798-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216798-001 | FENOFIBRATE | 54MG | TABLET / ORAL | AB | 2022-09-27 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216798-002 | FENOFIBRATE | 160MG | TABLET / ORAL | AB | 2022-09-27 | a67488948f0b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216798-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A216798-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216798-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216798-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216798-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A216798-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216798-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216798-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216798-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216798-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216798-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216798-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216798-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216798-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216798-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216798-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216798-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216798-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216798-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A216798-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216798-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216798-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216798-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216798-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216798-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216798-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A216798-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A216798-002 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216798-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216798-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A216798-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A216798-002 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A216798-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A216798-002 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216798-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216798-002 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216798-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216798-002 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216798-001 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216798-002 | AB | 1 | a67488948f0b… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Fenofibrate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FENOFIBRATE | 160 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U202363UOS | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 349287 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0b4e90dd-646b-afec-e063-6294a90a598e | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 193bb7da-5c03-8f95-9048-23ef403846b0 | Product name | 3 | 20250616 |
| fa35fb9a-7146-716b-13c8-bc1f60030232 | Product name | 9 | 20250114 |
| cfc78bfa-7d55-47e5-aeb7-71cd79f5ca07 | Product name | 8 | 20231212 |
| 53d5b6b7-785a-4500-9460-263c7f8424b8 | Product name | 5 | 20210105 |
| ed9d55d4-85bd-0ee7-5b4a-b705646a3a66 | Product name | 9 | 20200708 |
| 36a239c8-03fb-0083-81af-6c1afb195671 | Product name | 1 | 20140508 |
| a0296d70-ca85-018c-84e8-cf3f630976b7 | Product name | 1 | 20140508 |
| f2e3e9c8-a2f9-0cc3-a5a5-6dfd0279372a | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3542-9 | Fenofibrate | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3542 | FENOFIBRATE TABLET, FILM COATED [NUCARE PHARMACEUTICALS,INC.] | 2 | Current NDC, 1 package rows | 20250205_0b4e90dd-646b-afec-e063-6294a90a598e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fenofibrate | FENOFIBRATE | Bryant Ranch Prepack | bbeae8e4-e06a-4c19-a1b9-f6143306dab9 | 2026-02-16 | Warnings, Adverse reactions | 216798 ANDA216798 |
| Fenofibrate | FENOFIBRATE | A-S Medication Solutions | db3ac584-2c8e-4f69-b24c-96ddcca2c23f | 2025-10-16 | Warnings, Adverse reactions | 216798 ANDA216798 |
| Fenofibrate | FENOFIBRATE | A-S Medication Solutions | d26e21bf-6c54-437d-81fe-07220e450561 | 2025-10-16 | Warnings, Adverse reactions | 216798 ANDA216798 |
| Fenofibrate | FENOFIBRATE | A-S Medication Solutions | 556c4800-24f6-4237-8636-3211997cbb03 | 2025-06-10 | Warnings, Adverse reactions | 216798 ANDA216798 |
| Fenofibrate | FENOFIBRATE | Preferred Pharmaceuticals Inc. | 7792d680-76ee-4146-9451-b16c40656cc1 | 2025-04-11 | Warnings, Adverse reactions | 216798 ANDA216798 |
| Fenofibrate | FENOFIBRATE | Aurobindo Pharma Limited | a7cfa38f-b4db-40d3-8821-3f7c85e2727e | 2025-02-12 | Warnings, Adverse reactions | 216798 ANDA216798 |
| Fenofibrate | FENOFIBRATE | NuCare Pharmaceuticals,Inc. | 0b4e90dd-646b-afec-e063-6294a90a598e | 2025-02-03 | Warnings, Adverse reactions | 216798 ANDA216798 68071-3542-9 68071-3542 68071354209 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 349287 | fenofibrate 160 MG Oral Tablet | PSN | 0b4e90dd-646b-afec-e063-6294a90a598e | 2 |
| 349287 | fenofibrate 160 MG Oral Tablet | SCD | 0b4e90dd-646b-afec-e063-6294a90a598e | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 68071-3542-9 | 68071354209 | 90 TABLET, FILM COATED in 1 BOTTLE (68071-3542-9) | 2023-11-29 | No | No | Current |